GS-441524 is primarily used as an effective antiviral treatment for FIP, a life-threatening viral disease caused by the feline coronavirus. It helps reduce viral replication, alleviates symptoms, and improves survival rates in cats diagnosed with FIP.
Beyond FIP, GS-441524 holds potential for treating other viral infections in animals, including those caused by coronaviruses or other RNA viruses. It can be utilized in veterinary clinics to manage a broader range of viral diseases affecting pets and livestock.
As the active metabolite of Remdesivir, GS-441524 is also a subject of study for its potential in treating human viral infections, such as COVID-19 and other coronaviruses. Its effectiveness in animal models has led to research into its application in human medicine.



